Remedium Lifecare (REMLIFE) | Stock Overview & Key Data
Remedium Lifecare Performance Comparison
Stock Range
Today's Range
Low: ₹1.44
High: ₹1.54
on September 18, 2025
52 Week Range
Low: ₹0.80
High: ₹9.34
on June 25, 2025
on September 18, 2024
All-Time High: ₹4,547.80 on July 3, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.3B
EPS
0.06
P/E Ratio (TTM)
25.17
Forward P/E
N/A
P/B Ratio
1.41
PEG Ratio
0.32
Div. Yield
N/A
ROE
4.85%
Beta
1.202
Debt to Equity
2,600.51
Financial Highlights
Profitability
Gross Margin
4.88%
Operating Margin
1.65%
Profit Margin
1.17%
Returns and Earnings
Return on Assets (TTM)
0.12%
Return on Equity (TTM)
4.85%
EBITDA
INR116.4M
Net Income (TTM)
INR51.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR7.63
Quarterly Revenue Growth (YoY)
45.90%
Quarterly Earnings Growth (YoY)
184.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Remedium Lifecare REMLIFE | 1.33B Small-cap | -1.32% | 14.50% | 57.89% | -29.58% | -70.41% | -83.46% | -98.90% | -96.94% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 2.42% | 0.97% | 0.04% | -3.27% | -12.77% | -11.64% | 78.98% | 236.69% |
| Divi's Laboratories DIVISLAB | 1.62T Large-cap | 1.60% | -0.85% | -6.67% | 7.78% | 0.64% | 12.13% | 67.79% | 99.69% |
| Innova Captab INNOVACAP | 49.37B Small-cap | -0.29% | -5.29% | 0.45% | 8.94% | -22.70% | 7.89% | 58.40% | 58.40% |
| Sequent Scientific SEQUENT | 46.87B Small-cap | 8.21% | 13.07% | 2.39% | 51.46% | 7.55% | 14.50% | 86.47% | 35.74% |
| Sun Pharma Advanced SPARC | 46.74B Small-cap | -0.46% | 0.18% | -8.55% | 22.70% | -28.31% | -34.13% | -33.75% | -14.49% |
Ownership & Short Interest
Insider Ownership
22.61%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
14M
Average 90-Day Volume
8M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is REMLIFE's 52-week high and low?
- In the last 52 weeks, Remedium Lifecare reached a high of ₹9.34 (on September 18, 2024) and a low of ₹0.80 (on June 25, 2025).
- What is the market cap and P/E ratio for REMLIFE?
- Curious about Remedium Lifecare's size and valuation? Its market capitalization stands at 1.33B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.17, and the forward P/E (looking ahead) is N/A.
- Does REMLIFE pay dividends? If so, what's the yield?
- As for dividends, Remedium Lifecare isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Remedium Lifecare's main competitors or similar companies to consider before investing?
When looking at Remedium Lifecare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -11.64% 78.98% Divi's Laboratories
DIVISLAB1.62T Healthcare Drug Manufacturers - Specialty & Generic 12.13% 67.79% Innova Captab
INNOVACAP49.37B Healthcare Drug Manufacturers - Specialty & Generic 7.89% 58.40% Sequent Scientific
SEQUENT46.87B Healthcare Drug Manufacturers - Specialty & Generic 14.50% 86.47% Sun Pharma Advanced
SPARC46.74B Healthcare Drug Manufacturers - Specialty & Generic -34.13% -33.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Remedium Lifecare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Remedium Lifecare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.85%, the Debt to Equity ratio from the most recent quarter is 2,600.51, and its Gross Profit Margin stands at 4.88%.
- What is the recent revenue and earnings growth for REMLIFE?
- Looking at Remedium Lifecare's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.90%, and quarterly earnings saw a YoY growth of 184.20%.
- How much of REMLIFE stock is held by insiders and institutions?
- Wondering who owns Remedium Lifecare stock? Company insiders (like executives and directors) hold about 22.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.